サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1471959

プロテオミクス市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：製品・サービス別、用途別、エンドユーザー別、地域別

Proteomics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Service, Application, End User, and Geography

出版日
ページ情報
英文 150 Pages
納期
1～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
プロテオミクス市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：製品・サービス別、用途別、エンドユーザー別、地域別
出版日: 2024年03月12日
発行: The Insight Partners
ページ情報: 英文 150 Pages
納期: 1～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

「プロテオミクス市場の2030年までの予測-COVID-19の影響と世界分析- 製品・サービス別、用途別、エンドユーザー別」によると、同市場は2022年の270億7,000万米ドルから成長し、2030年には750億3,000万米ドルに達すると予測されており、2022年から2030年のCAGRは13.6%となる見込みです。市場成長の背景には、慢性疾患の急増とナノプロテオミクスの台頭があります。技術の進歩と研究開発費の増加は、プロテオミクス市場に成長機会をもたらすと思われます。しかし、機器のコストが高く、熟練した人材が少ないことがプロテオミクス市場の成長を妨げています。

プロテオミクスは、タンパク質の詳細な分析であり、医薬品開発、治療、予後、疾患の特徴を研究する重要な分野となっています。プロテオミクス技術は、感染症および非感染症の検出と治療に役立っています。現在のプロテオミクス手法は、ナノテクノロジーを技術基盤として利用することで、信頼性、生体適合性、特異性、再現性を高めています。従来のプロテオミクス手法の欠点は、タンパク質操作によってプロテオミクス手法の質を高めるナノ材料の使用によって大きく評価されます。製薬分野では、プロテオミクスは薬効や毒性のメカニズムを研究します。また、バイオマーカーの同定や有効性の確認にも広く利用されています。

2022年のプロテオミクス世界市場では、北米が大きなシェアを占めています。北米プロテオミクス市場は米国、カナダ、メキシコに区分されます。この地域の市場成長を促進する主な要因は、構造ベースのドラッグデザイン開発への投資の増加、データ再現性のための高品質研究ツールへの需要、オミックス研究の成長などです。オーダーメイド治療法の開発に注目が集まっています。地域の主要企業間の提携や協力関係も、この地域の市場拡大に貢献しています。例えば、サーモフィッシャーサイエンティフィック社とシンフォジェン社は、複雑な治療用タンパク質の最適な特性評価と品質モニタリングのための検証済みプラットフォームプロセスの開発で提携しています。また、米国などではプロテオミクス研究が最盛期を迎えています。

技術の進歩と研究開発費の増加が将来の市場機会をもたらす

プロテオミクス業界のメーカーは、疾患診断のための新しい手法や装置の提供に注力しています。Agilent Technologies, Inc.などの企業は、技術ライセンシング戦略を用いてタンパク質分析用製品の開発に注力することの利点を認識しています。タンパク質ベースの診断薬の絶対定量化は、プロテオミクス技術の利用によって可能になった。マイクロアレイ、X線結晶構造解析、分光技術、クロマトグラフィー、電気泳動、表面プラズマ共鳴システムなどの主要なプロテオミクス・サービスやその他の技術がプロテオミクス市場の基盤を形成しています。

プロテオミクスの研究開発への投資が増加していることが、市場の成長を促進しています。米国国立衛生研究所（NIH）は、生物医学研究に370億米ドルを拠出しました。この資金は、疾患発症の基本的メカニズムの研究、疾患の存在を示すバイオマーカーの特定、疾患の原因となる遺伝子やタンパク質の特定に役立てられます。ノボノルディスク財団は、コペンハーゲン大学に質量分析施設を建設するために最大150万米ドルを助成しました。COVID-19の発生後、市場は急速に勢いを増しました。

新興諸国では、人々の質の高いヘルスケアや医薬品へのアクセスを向上させ、経済的な展望も広げる上で、主なプレーヤーが極めて重要な存在であり、雇用の拡大、多額の投資、公共政策への影響力、研修の提供などを通じて、経済機会の拡大にも努めています。製薬業界は途上国の経済機会の成長に大きな影響を与えています。近年、製薬会社は素晴らしい業績を上げています。例えば、サーモフィッシャーサイエンティフィック社は昨年、過去最高益を記録し、今後の業績はさらに良くなると予測されています。複数のバイオ医薬品企業が主要プレーヤーとして台頭し、さまざまな研究開発活動が行われているため、世界市場に成長機会がもたらされ、市場は今後も繁栄し続けると思われます。

製品・サービス別の洞察

製品・サービス別に見ると、プロテオミクス市場は装置、試薬・消耗品、ソフトウェア・サービスに分けられます。試薬・消耗品セグメントは2022年に最大の市場シェアを占め、2022-2030年のCAGRは14.1%と最も高くなるとみられます。

試薬＆キット、消耗品、ストリップは、研究大学や研究機関などにおいて、さまざまな生物学的物質の研究にますます使用されるようになっています。プロテオミクスとゲノミクスの分野における政府のイニシアチブは、疾病診断の研究活動を推進しています。生物学的研究のスピード、効率、生産性を向上させる3D電気泳動タンパク質分析装置などの先端機器の技術的進歩も、試薬や消耗品の需要を促進しています。こうした要因が、同セグメントのプロテオミクス市場規模の拡大に寄与しています。

アプリケーション別の洞察

市場はアプリケーション別に、臨床診断、創薬・市場開拓、その他に分けられます。2022年のプロテオミクス市場シェアは、臨床診断分野が最大でした。しかし、創薬・開発セグメントは2022-2030年に14.4%と最も高いCAGRを記録する見込みです。

エンドユーザーに基づく洞察

エンドユーザーに基づき、市場は製薬＆バイオテクノロジー企業、研究＆臨床ラボ、病院、その他に区分されます。製薬＆バイオテクノロジー企業セグメントは、2022年にプロテオミクス市場で最大のシェアを占めました。しかし、研究＆臨床ラボセグメントは、2022-2030年の間に14.5％の最高のCAGRを記録すると推定されています。

大手企業は、ビジネスチャンスをつかむために、事業拡大、提携、新製品の発売、新規顧客基盤の獲得などの戦略を実施しています。

2022年1月、Seer, Inc.はCenters of ExcellenceプログラムのデビューとProteograph Product Suiteの商用リリースを発表しました。Proteograph Product Suiteは、プロテオームへの偏りのない、比類のないアクセスを提供します。このアプローチでは、独自に設計されたナノ粒子を使用し、迅速かつ徹底的で偏りのない大規模プロテオミクスを可能にする画期的な製品を製造します。

2021年2月、Agilent Technologies Inc.は、ヒト血清または血漿中のSARS-CoV-2に対する免疫グロブリンG（IgG）抗体を定性的に検出するために設計されたAgilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay（ELISA）キットを発売しました。

2021年2月、Poochon Scientific, LLCはBioPharmaオプションとFAIMS Proインターフェースを備えた新しいThermo Orbitrap Exploris 240質量分析計を取得しました。この質量分析計は、プロテオミクス、メタボロミクス、バイオ医薬品の特性解析に卓越した性能を発揮する汎用性の高い新世代の高分解能質量分析計です。

米国食品医薬品局（FDA）、疾病対策予防センター（CDC）、世界疾病負担調査（Global Burden of Disease Study）は、プロテオミクス市場レポート作成時に参照した一次情報および二次情報のひとつです。

目次

第1章 イントロダクション

第2章 要点

第3章 調査手法

第4章 プロテオミクス市場情勢

  • 概観
  • PEST分析
    • 北米：PEST分析
    • 欧州-PEST分析
    • アジア太平洋-PEST分析
    • 中東・アフリカ-PEST分析
    • 中南米-PEST分析
  • 専門家の見解

第5章 プロテオミクス市場：主要市場力学

  • 市場促進要因
  • 主要市場抑制要因
  • 主な市場機会
  • 将来の動向
  • 促進要因と抑制要因の影響分析

第6章 プロテオミクス世界市場分析

  • プロテオミクス-世界市場概要
  • プロテオミクス-世界市場と2028年までの予測
  • 市場のポジショニング

第7章 プロテオミクス市場：2028年までの収益と予測：機器

  • スペクトロスコピー
    • 質量分析装置
    • NMR分光法
    • 円偏光二色性（CD）分光法
  • クロマトグラフィー
    • HPLC市場
    • イオンクロマトグラフィー
    • イオンクロマトグラフィー
    • 超臨界流体クロマトグラフィー
  • 電気泳動
    • ゲル電気泳動
    • キャピラリー電気泳動
  • プロテインマイクロアレイ
    • バイオチップ
    • マイクロアレイ機器
  • X線結晶構造解析
  • 表面プラズモン共鳴
  • タンパク質分画
  • その他の機器

第8章 プロテオミクス市場：2028年までの収益と予測：試薬

  • 免疫測定試薬
  • 分光試薬
  • クロマトグラフィー試薬
  • プロテインマイクロアレイ試薬
  • X線結晶構造解析試薬
  • 電気泳動試薬
  • タンパク質分画試薬

第9章 プロテオミクス市場：2028年までの収益と予測：サービスとソフトウェア

  • サービス
    • タンパク質同定サービス
    • 定量プロテオミクスサービス
    • タンパク質精製サービス
    • タンパク質分離サービス
    • タンパク質シーケンスサービス
    • その他サービス
  • ソフトウェア
    • バイオインフォマティクスサービス
    • バイオインフォマティクスツール
    • バイオインフォマティクスデータベース

第10章 プロテオミクス市場：2028年までの収益と予測：用途

  • 臨床診断
  • 創薬
  • その他の用途

第11章 プロテオミクス市場：2028年までの収益と予測：地域分析

  • 北米
    • 北米
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 欧州
      • ドイツ
      • フランス
      • イタリア
      • スペイン
      • 英国
      • その他欧州
  • アジア太平洋
    • アジア太平洋
      • オーストラリア
      • 中国
      • インド
      • 日本
      • 韓国
      • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ
      • 南アフリカ
      • サウジアラビア
      • アラブ首長国連邦
      • その他中東とアフリカ
  • 中南米
    • 中南米
      • ブラジル
      • アルゼンチン
      • その他中南米

第12章 COVID-19パンデミックがプロテオミクスの世界市場に与える影響

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第13章 業界情勢

  • 合併と買収
  • 契約、提携、合弁事業
  • 新製品の発売
  • 事業拡大とその他の戦略的展開

第14章 プロテオミクス市場：主要企業プロファイル

  • THERMO FISHER SCIENTIFIC INC.
  • BIO-RAD LABORATORIES, INC.
  • AGILENT TECHNOLOGIES
  • DANAHER
  • PERKINELMER INC.
  • MERCK KGAA
  • LUMINEX CORPORATION
  • GENERAL ELECTRIC COMPANY
目次
Product Code: TIPHE100001115

According to our new research study on "Proteomics Market Forecast to 2030 - COVID-19 Impact and Global Analysis - by Product & Service, Application, and End User," the market is anticipated to grow from US$ 27.07 billion in 2022 and is projected to reach US$ 75.03 billion by 2030; it is expected to register a CAGR of 13.6% during 2022-2030. Market growth is attributed to the proliferating cases of chronic diseases and the growing prominence of nano proteomics. Growing technological advancements and R&D expenditure will likely provide growth opportunities for the proteomics market. However, the high costs of instruments and the dearth of skilled personnel hinder the growth of the proteomics market.

Proteomics, the detailed analysis of proteins, has become a significant field to study drug development, therapy, prognosis, and disease characterization. Proteomics technologies help with both infectious and noninfectious disease detection and therapy. The current proteomic methodologies are being made more reliable, biocompatible, specific, and reproducible through the use of nanotechnology as a technological platform. The shortcomings of conventional proteomic techniques are greatly assessed with the use of nanomaterials to enhance the quality of proteomic techniques by protein manipulation. In the pharmaceutical field, proteomics studies drug effects or the mechanism of toxicity. They are also widely used to identify and confirm the effectiveness of biomarkers.

North America accounted for a major share of the global proteomics market in 2022. The North American proteomics market is segmented into the US, Canada, and Mexico. The key factors driving the market growth in this region is the increasing investments in the development of structure-based drug design, demand for high-quality research tools for data reproducibility, growth in omics research, etc. Attention is being paid to the development of tailor-made treatments. Partnerships and collaborations between major regional companies also contribute to the market expansion in the region. For example, Thermo Fisher Scientific Inc. and Symphogen have collaborated to develop verified platform processes for optimized characterization and quality monitoring of complex therapeutic proteins. Also, proteomics research is at its peak in countries like the US.

Growing Technological Advancements and R&D Expenditure to Provide Market Opportunities in the Future

Manufacturers in the proteomics industry are focused on providing new methods and devices for disease diagnosis. Companies such as Agilent Technologies, Inc. have recognized the advantages of using technology out-licensing strategies to focus on developing products for protein analysis. The absolute quantification of protein-based diagnostics was made possible through the use of proteomics technology. Key proteomic services and other technologies, including microarray, X-ray crystallography, spectroscopic techniques, chromatography, electrophoresis, and surface plasma resonance systems, form the foundation of the proteomics market.

The increasing investments in research and development in proteomics are fostering market growth. The US National Institutes of Health (NIH) gave US$ 37 billion for biomedical research. This funding will aid in studying the fundamental mechanisms of disease development, identifying biomarkers that indicate the presence of a disease, or identifying the gene or protein that causes the disease. The Novo Nordisk Foundation granted the University of Copenhagen a grant of up to US$ 1.5 million to build a mass spectrometry facility, an important step toward protein research. The market quickly gained momentum after the outbreak of COVID-19.

Key players are crucial in improving people's access to quality healthcare and medicines in developing countries, which also expands their economic prospects, and they are also working to increase economic opportunities by creating more jobs, making significant investments, influencing public policy, and providing trainings. The pharmaceutical industry has a significant impact on the growth of economic opportunities in developing countries. In recent years, pharmaceutical companies have achieved excellent financial results. For example, Thermo Fisher Scientific, Inc. posted record profits last year, and future performance is predicted to be even better. The market will continue to flourish as several biopharmaceutical companies are emerging as key players and various R&D activities are being conducted, thereby providing growth opportunities for the global market.

Product & Service -Based Insights

Based on product & service, the proteomics market is divided into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment held the largest market share in 2022 and is likely to register the highest CAGR of 14.1% during 2022-2030.

Reagents & kits, consumables, and strips are increasingly used for studying various biological materials in research universities, research institutions, and other areas. Government initiatives in the field of proteomics and genomics are propelling research activities in disease diagnostics. Technical advancements in advanced instruments, such as 3D electrophoresis protein analyzers, which increase biological research's speed, efficiency, and productivity, are also propelling the demand for reagents and consumables. These factors are contributing to the growing proteomics market size for the segment.

Application -Based Insights

The market, based on application, is divided into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest proteomics market share in 2022. However, the drug discovery & development segment is expected to register the highest CAGR of 14.4% during 2022-2030.

End User -Based Insights

Based on end user, the market is segmented into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, others. The pharmaceutical & biotechnology companies segment held the largest proteomics market share in 2022. However, the research & clinical laboratories segment is estimated to register the highest CAGR of 14.5% during 2022-2030.

Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquisition of a new customer base for tapping prevailing business opportunities.

In January 2022, Seer, Inc. announced the debut of the Centers of Excellence program and the commercial release of the Proteograph Product Suite. The Proteograph Product Suite provides unbiased, unmatched access to the proteome. The approach uses uniquely designed nanoparticles to produce a breakthrough product that enables rapid, thorough, and unbiased large-scale proteomics.

In February 2021, Agilent Technologies Inc. launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit, designed for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.

In February 2021, Poochon Scientific, LLC acquired a new Thermo Orbitrap Exploris 240 mass spectrometer that has BioPharma option and FAIMS Pro interface. It is a versatile, new-generation, high-resolution mass spectrometer that offers exceptional performance for proteomics, metabolomics, and biopharmaceutical characterization.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the proteomics market report.

Table Of Contents

1. INTRODUCTION

  • 1.1. SCOPE OF THE STUDY
  • 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
  • 1.3. MARKET SEGMENTATION
    • 1.3.1 Proteomics Market - By Instrument
    • 1.3.2 Proteomics Market - By Reagents
    • 1.3.3 Proteomics Market - By Services and Software
    • 1.3.4 Proteomics Market - By Application
    • 1.3.5 Proteomics Market - By Region
      • 1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PROTEOMICS MARKET LANDSCAPE

  • 4.1. OVERVIEW
  • 4.2. PEST ANALYSIS
    • 4.2.1 North America - Pest Analysis
    • 4.2.2 Europe - Pest Analysis
    • 4.2.3 Asia-Pacific - Pest Analysis
    • 4.2.4 Middle East and Africa - Pest Analysis
    • 4.2.5 South and Central America - Pest Analysis
  • 4.3. EXPERT OPINIONS

5. PROTEOMICS MARKET - KEY MARKET DYNAMICS

  • 5.1. KEY MARKET DRIVERS
  • 5.2. KEY MARKET RESTRAINTS
  • 5.3. KEY MARKET OPPORTUNITIES
  • 5.4. FUTURE TRENDS
  • 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROTEOMICS MARKET - GLOBAL MARKET ANALYSIS

  • 6.1. PROTEOMICS - GLOBAL MARKET OVERVIEW
  • 6.2. PROTEOMICS - GLOBAL MARKET AND FORECAST TO 2028
  • 6.3. MARKET POSITIONING

7. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - INSTRUMENT

  • 7.1. OVERVIEW
  • 7.2. INSTRUMENT MARKET FORECASTS AND ANALYSIS
  • 7.3. SPECTROSCOPY
    • 7.3.1. Overview
    • 7.3.2. Spectroscopy Market Forecast and Analysis
    • 7.3.3. Mass Spectroscopy Market
      • 7.3.3.1. Overview
      • 7.3.3.2. Mass Spectroscopy Market Forecast and Analysis
    • 7.3.4. NMR Spectroscopy Market
      • 7.3.4.1. Overview
      • 7.3.4.2. NMR Spectroscopy Market Forecast and Analysis
    • 7.3.5. Circular Dichroism (CD) Spectroscopy Market
      • 7.3.5.1. Overview
      • 7.3.5.2. Circular Dichroism (CD) Spectroscopy Market Forecast and Analysis
  • 7.4. CHROMATOGRAPHY
    • 7.4.1. Overview
    • 7.4.2. Chromatography Market Forecast and Analysis
    • 7.4.3. HPLC Market
      • 7.4.3.1. Overview
      • 7.4.3.2. HPLC Market Forecast and Analysis
    • 7.4.4. Ion Chromatography Market
      • 7.4.4.1. Overview
      • 7.4.4.2. Ion Chromatography Market Forecast and Analysis
    • 7.4.5. Ion Chromatography Market
      • 7.4.5.1. Overview
      • 7.4.5.2. Ion Chromatography Market Forecast and Analysis
    • 7.4.6. Supercritical Fluid Chromatography Market
      • 7.4.6.1. Overview
      • 7.4.6.2. Supercritical Fluid Chromatography Market Forecast and Analysis
  • 7.5. ELECTROPHORESIS
    • 7.5.1. Overview
    • 7.5.2. Electrophoresis Market Forecast and Analysis
    • 7.5.3. Gel Electrophoresis Market
      • 7.5.3.1. Overview
      • 7.5.3.2. Gel Electrophoresis Market Forecast and Analysis
    • 7.5.4. Capillary Electrophoresis Market
      • 7.5.4.1. Overview
      • 7.5.4.2. Capillary Electrophoresis Market Forecast and Analysis
  • 7.6. PROTEIN MICROARRAYS
    • 7.6.1. Overview
    • 7.6.2. Protein Microarrays Market Forecast and Analysis
    • 7.6.3. Biochips Market
      • 7.6.3.1. Overview
      • 7.6.3.2. Biochips Market Forecast and Analysis
    • 7.6.4. Microarray Instruments Market
      • 7.6.4.1. Overview
      • 7.6.4.2. Microarray Instruments Market Forecast and Analysis
  • 7.7. X-RAY CRYSTALLOGRAPHY
    • 7.7.1. Overview
    • 7.7.2. X-Ray Crystallography Market Forecast and Analysis
  • 7.8. SURFACE PLASMON RESONANCE
    • 7.8.1. Overview
    • 7.8.2. Surface Plasmon Resonance Market Forecast and Analysis
  • 7.9. PROTEIN FRACTIONATION
    • 7.9.1. Overview
    • 7.9.2. Protein Fractionation Market Forecast and Analysis
  • 7.10. OTHER INSTRUMENT
    • 7.10.1. Overview
    • 7.10.2. Other Instrument Market Forecast and Analysis

8. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - REAGENTS

  • 8.1. OVERVIEW
  • 8.2. REAGENTS MARKET FORECASTS AND ANALYSIS
  • 8.3. IMMUNOASSAY REAGENTS
    • 8.3.1. Overview
    • 8.3.2. Immunoassay Reagents Market Forecast and Analysis
  • 8.4. SPECTROSCOPY REAGENTS
    • 8.4.1. Overview
    • 8.4.2. Spectroscopy Reagents Market Forecast and Analysis
  • 8.5. CHROMATOGRAPHY REAGENTS
    • 8.5.1. Overview
    • 8.5.2. Chromatography Reagents Market Forecast and Analysis
  • 8.6. PROTEIN MICROARRAY REAGENTS
    • 8.6.1. Overview
    • 8.6.2. Protein Microarray Reagents Market Forecast and Analysis
  • 8.7. X-RAY CRYSTALLOGRAPHY REAGENTS
    • 8.7.1. Overview
    • 8.7.2. X-Ray Crystallography Reagents Market Forecast and Analysis
  • 8.8. ELECTROPHORESIS REAGENTS
    • 8.8.1. Overview
    • 8.8.2. Electrophoresis Reagents Market Forecast and Analysis
  • 8.9. PROTEIN FRACTIONATION REAGENTS
    • 8.9.1. Overview
    • 8.9.2. Protein Fractionation Reagents Market Forecast and Analysis

9. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - SERVICES AND SOFTWARE

  • 9.1. OVERVIEW
  • 9.2. SERVICES AND SOFTWARE MARKET FORECASTS AND ANALYSIS
  • 9.3. SERVICES
    • 9.3.1. Overview
    • 9.3.2. Services Market Forecast and Analysis
    • 9.3.3. Protein Identification Services Market
      • 9.3.3.1. Overview
      • 9.3.3.2. Protein Identification Services Market Forecast and Analysis
    • 9.3.4. Quantitative Proteomics Services Market
      • 9.3.4.1. Overview
      • 9.3.4.2. Quantitative Proteomics Services Market Forecast and Analysis
    • 9.3.5. Protein Purification Services Market
      • 9.3.5.1. Overview
      • 9.3.5.2. Protein Purification Services Market Forecast and Analysis
    • 9.3.6. Protein Separation Services Market
      • 9.3.6.1. Overview
      • 9.3.6.2. Protein Separation Services Market Forecast and Analysis
    • 9.3.7. Protein Sequencing Services Market
      • 9.3.7.1. Overview
      • 9.3.7.2. Protein Sequencing Services Market Forecast and Analysis
    • 9.3.8. Others Services Market
      • 9.3.8.1. Overview
      • 9.3.8.2. Others Services Market Forecast and Analysis
  • 9.4. SOFTWARE
    • 9.4.1. Overview
    • 9.4.2. Software Market Forecast and Analysis
    • 9.4.3. Bioinformatics Services Market
      • 9.4.3.1. Overview
      • 9.4.3.2. Bioinformatics Services Market Forecast and Analysis
    • 9.4.4. Bioinformatics Tools Market
      • 9.4.4.1. Overview
      • 9.4.4.2. Bioinformatics Tools Market Forecast and Analysis
    • 9.4.5. Bioinformatics Databases Market
      • 9.4.5.1. Overview
      • 9.4.5.2. Bioinformatics Databases Market Forecast and Analysis

10. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION

  • 10.1. OVERVIEW
  • 10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
  • 10.3. CLINICAL DIAGNOSTICS
    • 10.3.1. Overview
    • 10.3.2. Clinical Diagnostics Market Forecast and Analysis
  • 10.4. DRUG DISCOVERY
    • 10.4.1. Overview
    • 10.4.2. Drug Discovery Market Forecast and Analysis
  • 10.5. OTHER APPLICATIONS
    • 10.5.1. Overview
    • 10.5.2. Other Applications Market Forecast and Analysis

11. PROTEOMICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1 North America Proteomics Market Overview
    • 11.1.2 North America Proteomics Market Forecasts and Analysis
    • 11.1.3 North America Proteomics Market Forecasts and Analysis - By Instrument
    • 11.1.4 North America Proteomics Market Forecasts and Analysis - By Reagents
    • 11.1.5 North America Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.1.6 North America Proteomics Market Forecasts and Analysis - By Application
    • 11.1.7 North America Proteomics Market Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Proteomics Market
        • 11.1.7.1.1 United States Proteomics Market by Instrument
        • 11.1.7.1.2 United States Proteomics Market by Reagents
        • 11.1.7.1.3 United States Proteomics Market by Services and Software
        • 11.1.7.1.4 United States Proteomics Market by Application
      • 11.1.7.2 Canada Proteomics Market
        • 11.1.7.2.1 Canada Proteomics Market by Instrument
        • 11.1.7.2.2 Canada Proteomics Market by Reagents
        • 11.1.7.2.3 Canada Proteomics Market by Services and Software
        • 11.1.7.2.4 Canada Proteomics Market by Application
      • 11.1.7.3 Mexico Proteomics Market
        • 11.1.7.3.1 Mexico Proteomics Market by Instrument
        • 11.1.7.3.2 Mexico Proteomics Market by Reagents
        • 11.1.7.3.3 Mexico Proteomics Market by Services and Software
        • 11.1.7.3.4 Mexico Proteomics Market by Application
  • 11.2. EUROPE
    • 11.2.1 Europe Proteomics Market Overview
    • 11.2.2 Europe Proteomics Market Forecasts and Analysis
    • 11.2.3 Europe Proteomics Market Forecasts and Analysis - By Instrument
    • 11.2.4 Europe Proteomics Market Forecasts and Analysis - By Reagents
    • 11.2.5 Europe Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.2.6 Europe Proteomics Market Forecasts and Analysis - By Application
    • 11.2.7 Europe Proteomics Market Forecasts and Analysis - By Countries
      • 11.2.7.1 Germany Proteomics Market
        • 11.2.7.1.1 Germany Proteomics Market by Instrument
        • 11.2.7.1.2 Germany Proteomics Market by Reagents
        • 11.2.7.1.3 Germany Proteomics Market by Services and Software
        • 11.2.7.1.4 Germany Proteomics Market by Application
      • 11.2.7.2 France Proteomics Market
        • 11.2.7.2.1 France Proteomics Market by Instrument
        • 11.2.7.2.2 France Proteomics Market by Reagents
        • 11.2.7.2.3 France Proteomics Market by Services and Software
        • 11.2.7.2.4 France Proteomics Market by Application
      • 11.2.7.3 Italy Proteomics Market
        • 11.2.7.3.1 Italy Proteomics Market by Instrument
        • 11.2.7.3.2 Italy Proteomics Market by Reagents
        • 11.2.7.3.3 Italy Proteomics Market by Services and Software
        • 11.2.7.3.4 Italy Proteomics Market by Application
      • 11.2.7.4 Spain Proteomics Market
        • 11.2.7.4.1 Spain Proteomics Market by Instrument
        • 11.2.7.4.2 Spain Proteomics Market by Reagents
        • 11.2.7.4.3 Spain Proteomics Market by Services and Software
        • 11.2.7.4.4 Spain Proteomics Market by Application
      • 11.2.7.5 United Kingdom Proteomics Market
        • 11.2.7.5.1 United Kingdom Proteomics Market by Instrument
        • 11.2.7.5.2 United Kingdom Proteomics Market by Reagents
        • 11.2.7.5.3 United Kingdom Proteomics Market by Services and Software
        • 11.2.7.5.4 United Kingdom Proteomics Market by Application
      • 11.2.7.6 Rest of Europe Proteomics Market
        • 11.2.7.6.1 Rest of Europe Proteomics Market by Instrument
        • 11.2.7.6.2 Rest of Europe Proteomics Market by Reagents
        • 11.2.7.6.3 Rest of Europe Proteomics Market by Services and Software
        • 11.2.7.6.4 Rest of Europe Proteomics Market by Application
  • 11.3. ASIA-PACIFIC
    • 11.3.1 Asia-Pacific Proteomics Market Overview
    • 11.3.2 Asia-Pacific Proteomics Market Forecasts and Analysis
    • 11.3.3 Asia-Pacific Proteomics Market Forecasts and Analysis - By Instrument
    • 11.3.4 Asia-Pacific Proteomics Market Forecasts and Analysis - By Reagents
    • 11.3.5 Asia-Pacific Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.3.6 Asia-Pacific Proteomics Market Forecasts and Analysis - By Application
    • 11.3.7 Asia-Pacific Proteomics Market Forecasts and Analysis - By Countries
      • 11.3.7.1 Australia Proteomics Market
        • 11.3.7.1.1 Australia Proteomics Market by Instrument
        • 11.3.7.1.2 Australia Proteomics Market by Reagents
        • 11.3.7.1.3 Australia Proteomics Market by Services and Software
        • 11.3.7.1.4 Australia Proteomics Market by Application
      • 11.3.7.2 China Proteomics Market
        • 11.3.7.2.1 China Proteomics Market by Instrument
        • 11.3.7.2.2 China Proteomics Market by Reagents
        • 11.3.7.2.3 China Proteomics Market by Services and Software
        • 11.3.7.2.4 China Proteomics Market by Application
      • 11.3.7.3 India Proteomics Market
        • 11.3.7.3.1 India Proteomics Market by Instrument
        • 11.3.7.3.2 India Proteomics Market by Reagents
        • 11.3.7.3.3 India Proteomics Market by Services and Software
        • 11.3.7.3.4 India Proteomics Market by Application
      • 11.3.7.4 Japan Proteomics Market
        • 11.3.7.4.1 Japan Proteomics Market by Instrument
        • 11.3.7.4.2 Japan Proteomics Market by Reagents
        • 11.3.7.4.3 Japan Proteomics Market by Services and Software
        • 11.3.7.4.4 Japan Proteomics Market by Application
      • 11.3.7.5 South Korea Proteomics Market
        • 11.3.7.5.1 South Korea Proteomics Market by Instrument
        • 11.3.7.5.2 South Korea Proteomics Market by Reagents
        • 11.3.7.5.3 South Korea Proteomics Market by Services and Software
        • 11.3.7.5.4 South Korea Proteomics Market by Application
      • 11.3.7.6 Rest of Asia-Pacific Proteomics Market
        • 11.3.7.6.1 Rest of Asia-Pacific Proteomics Market by Instrument
        • 11.3.7.6.2 Rest of Asia-Pacific Proteomics Market by Reagents
        • 11.3.7.6.3 Rest of Asia-Pacific Proteomics Market by Services and Software
        • 11.3.7.6.4 Rest of Asia-Pacific Proteomics Market by Application
  • 11.4. MIDDLE EAST AND AFRICA
    • 11.4.1 Middle East and Africa Proteomics Market Overview
    • 11.4.2 Middle East and Africa Proteomics Market Forecasts and Analysis
    • 11.4.3 Middle East and Africa Proteomics Market Forecasts and Analysis - By Instrument
    • 11.4.4 Middle East and Africa Proteomics Market Forecasts and Analysis - By Reagents
    • 11.4.5 Middle East and Africa Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.4.6 Middle East and Africa Proteomics Market Forecasts and Analysis - By Application
    • 11.4.7 Middle East and Africa Proteomics Market Forecasts and Analysis - By Countries
      • 11.4.7.1 South Africa Proteomics Market
        • 11.4.7.1.1 South Africa Proteomics Market by Instrument
        • 11.4.7.1.2 South Africa Proteomics Market by Reagents
        • 11.4.7.1.3 South Africa Proteomics Market by Services and Software
        • 11.4.7.1.4 South Africa Proteomics Market by Application
      • 11.4.7.2 Saudi Arabia Proteomics Market
        • 11.4.7.2.1 Saudi Arabia Proteomics Market by Instrument
        • 11.4.7.2.2 Saudi Arabia Proteomics Market by Reagents
        • 11.4.7.2.3 Saudi Arabia Proteomics Market by Services and Software
        • 11.4.7.2.4 Saudi Arabia Proteomics Market by Application
      • 11.4.7.3 U.A.E Proteomics Market
        • 11.4.7.3.1 U.A.E Proteomics Market by Instrument
        • 11.4.7.3.2 U.A.E Proteomics Market by Reagents
        • 11.4.7.3.3 U.A.E Proteomics Market by Services and Software
        • 11.4.7.3.4 U.A.E Proteomics Market by Application
      • 11.4.7.4 Rest of Middle East and Africa Proteomics Market
        • 11.4.7.4.1 Rest of Middle East and Africa Proteomics Market by Instrument
        • 11.4.7.4.2 Rest of Middle East and Africa Proteomics Market by Reagents
        • 11.4.7.4.3 Rest of Middle East and Africa Proteomics Market by Services and Software
        • 11.4.7.4.4 Rest of Middle East and Africa Proteomics Market by Application
  • 11.5. SOUTH AND CENTRAL AMERICA
    • 11.5.1 South and Central America Proteomics Market Overview
    • 11.5.2 South and Central America Proteomics Market Forecasts and Analysis
    • 11.5.3 South and Central America Proteomics Market Forecasts and Analysis - By Instrument
    • 11.5.4 South and Central America Proteomics Market Forecasts and Analysis - By Reagents
    • 11.5.5 South and Central America Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.5.6 South and Central America Proteomics Market Forecasts and Analysis - By Application
    • 11.5.7 South and Central America Proteomics Market Forecasts and Analysis - By Countries
      • 11.5.7.1 Brazil Proteomics Market
        • 11.5.7.1.1 Brazil Proteomics Market by Instrument
        • 11.5.7.1.2 Brazil Proteomics Market by Reagents
        • 11.5.7.1.3 Brazil Proteomics Market by Services and Software
        • 11.5.7.1.4 Brazil Proteomics Market by Application
      • 11.5.7.2 Argentina Proteomics Market
        • 11.5.7.2.1 Argentina Proteomics Market by Instrument
        • 11.5.7.2.2 Argentina Proteomics Market by Reagents
        • 11.5.7.2.3 Argentina Proteomics Market by Services and Software
        • 11.5.7.2.4 Argentina Proteomics Market by Application
      • 11.5.7.3 Rest of South and Central America Proteomics Market
        • 11.5.7.3.1 Rest of South and Central America Proteomics Market by Instrument
        • 11.5.7.3.2 Rest of South and Central America Proteomics Market by Reagents
        • 11.5.7.3.3 Rest of South and Central America Proteomics Market by Services and Software
        • 11.5.7.3.4 Rest of South and Central America Proteomics Market by Application

12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROTEOMICS MARKET

  • 12.1 North America
  • 12.2 Europe
  • 12.3 Asia-Pacific
  • 12.4 Middle East and Africa
  • 12.5 South and Central America

13. INDUSTRY LANDSCAPE

  • 13.1. MERGERS AND ACQUISITIONS
  • 13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
  • 13.3. NEW PRODUCT LAUNCHES
  • 13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. PROTEOMICS MARKET, KEY COMPANY PROFILES

  • 14.1. THERMO FISHER SCIENTIFIC INC.
    • 14.1.1. Key Facts
    • 14.1.2. Business Description
    • 14.1.3. Products and Services
    • 14.1.4. Financial Overview
    • 14.1.5. SWOT Analysis
    • 14.1.6. Key Developments
  • 14.2. BIO-RAD LABORATORIES, INC.
    • 14.2.1. Key Facts
    • 14.2.2. Business Description
    • 14.2.3. Products and Services
    • 14.2.4. Financial Overview
    • 14.2.5. SWOT Analysis
    • 14.2.6. Key Developments
  • 14.3. AGILENT TECHNOLOGIES
    • 14.3.1. Key Facts
    • 14.3.2. Business Description
    • 14.3.3. Products and Services
    • 14.3.4. Financial Overview
    • 14.3.5. SWOT Analysis
    • 14.3.6. Key Developments
  • 14.4. DANAHER
    • 14.4.1. Key Facts
    • 14.4.2. Business Description
    • 14.4.3. Products and Services
    • 14.4.4. Financial Overview
    • 14.4.5. SWOT Analysis
    • 14.4.6. Key Developments
  • 14.5. PERKINELMER INC.
    • 14.5.1. Key Facts
    • 14.5.2. Business Description
    • 14.5.3. Products and Services
    • 14.5.4. Financial Overview
    • 14.5.5. SWOT Analysis
    • 14.5.6. Key Developments
  • 14.6. MERCK KGAA
    • 14.6.1. Key Facts
    • 14.6.2. Business Description
    • 14.6.3. Products and Services
    • 14.6.4. Financial Overview
    • 14.6.5. SWOT Analysis
    • 14.6.6. Key Developments
  • 14.7. LUMINEX CORPORATION
    • 14.7.1. Key Facts
    • 14.7.2. Business Description
    • 14.7.3. Products and Services
    • 14.7.4. Financial Overview
    • 14.7.5. SWOT Analysis
    • 14.7.6. Key Developments
  • 14.8. GENERAL ELECTRIC COMPANY
    • 14.8.1. Key Facts
    • 14.8.2. Business Description
    • 14.8.3. Products and S